Duloxetine DR may also cause side effects including but not limited to nausea, dry mouth, drowsiness, headache, fatigue, weight loss
Switching to a different GLP-1 If cost is the primary driver, switching from tirzepatide to semaglutide may offer a more affordable alternative while maintaining GLP-1 receptor activation
However, the combination has not been studied in large-scale clinical trials, so the full interaction profile, especially regarding side effects, remains an area for further research
The question is whether the experiment requires KPV
By distribution channel, the retail pharmacies segment generated the biggest market share of approximately 60% in 2025